Literature DB >> 4010473

Evidence for the mode of antischistosomal action of hycanthone.

D Cioli, L Pica-Mattoccia, S Rosenberg, S Archer.   

Abstract

Evidence is presented which supports the hypothesis that the mode of action, or a slight variant thereof, suggested by Hartman and Hulbert (11) to account for the mutagenic effects of hycanthone (HC) is the mechanism whereby HC exerts its antischistosomal activity. HC is metabolically activated to a reactive ester which, upon dissociation, alkylates DNA. If resistant schistosomes are unaffected because they cannot convert HC to a reactive ester they should be killed upon direct exposure to an appropriately esterified drug. Hycanthone N-methylcarbamate (HNMC) was synthesized and shown to bind to DNA and also alkylate 4-(p-nitrobenzyl)-pyridine. When tested with schistosomes kept in vitro, HNMC caused an irreversible inhibition of 3H-uridine incorporation not only in sensitive S. mansoni (as HC does) but also in HC-resistant and immature S. mansoni worms and S. japonicum worms which are only transiently inhibited by HC. After in vitro contact with HNMC for 1 h both sensitive and resistant schistosomes died in three weeks if either kept in culture or re-transplanted into the host animal. Mice infected with HC-resistant schistosomes showed a drastic worm reduction after in vivo HNMC administration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4010473     DOI: 10.1016/0024-3205(85)90419-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Inhibition of in vitro RNA synthesis by hycanthone, oxamniquine and praziquantel.

Authors:  L J Wong; G C Tsao; J I Bruce; S S Wong
Journal:  Experientia       Date:  1990-05-15

2.  Characterization of a programmed alteration in an 18S ribosomal gene that accompanies the experimental induction of drug resistance in Schistosoma mansoni.

Authors:  P J Brindley; S Heath; A P Waters; T F McCutchan; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

3.  Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites.

Authors:  Claudia L L Valentim; Donato Cioli; Frédéric D Chevalier; Xiaohang Cao; Alexander B Taylor; Stephen P Holloway; Livia Pica-Mattoccia; Alessandra Guidi; Annalisa Basso; Isheng J Tsai; Matthew Berriman; Claudia Carvalho-Queiroz; Marcio Almeida; Hector Aguilar; Doug E Frantz; P John Hart; Philip T LoVerde; Timothy J C Anderson
Journal:  Science       Date:  2013-11-21       Impact factor: 47.728

4.  Structural and Functional Characterization of the Enantiomers of the Antischistosomal Drug Oxamniquine.

Authors:  Alexander B Taylor; Livia Pica-Mattoccia; Chiara M Polcaro; Enrica Donati; Xiaohang Cao; Annalisa Basso; Alessandra Guidi; Anastasia R Rugel; Stephen P Holloway; Timothy J C Anderson; P John Hart; Donato Cioli; Philip T LoVerde
Journal:  PLoS Negl Trop Dis       Date:  2015-10-20

5.  Schistosome Sulfotransferases: Mode of Action, Expression and Localization.

Authors:  Meghan A Guzman; Anastasia Rugel; Sevan N Alwan; Reid Tarpley; Alexander B Taylor; Frédéric D Chevalier; George R Wendt; James J Collins; Timothy J C Anderson; Stanton F McHardy; Philip T LoVerde
Journal:  Pharmaceutics       Date:  2022-07-06       Impact factor: 6.525

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.